U.S. REITS Stock News

NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Regeneron’s Dupixent Win And Telix Deal Add New Layers To Valuation

The European Commission approved Dupixent as the first targeted treatment for moderate to severe chronic spontaneous urticaria in children aged 2 to 11 across the EU. Regeneron Pharmaceuticals and Telix Pharmaceuticals entered a new radiopharmaceuticals collaboration focused on next generation precision oncology therapies. Regeneron Pharmaceuticals (NasdaqGS:REGN) is adding fresh pieces to its story in both immunology and oncology. The stock trades around $753.93 and has returned 38.0% over...
NasdaqGS:UFPI
NasdaqGS:UFPIBuilding

A Look At UFP Industries (UFPI) Valuation As Sales And Earnings Declines Pressure Profitability

Recent commentary on UFP Industries (UFPI) points to sales declining by 6.4% annually and an even steeper fall in earnings per share, raising fresh questions about the strength of its profit centers. See our latest analysis for UFP Industries. At a share price of $93.02, UFP Industries has had a 3.45% 1 month share price return but a 13.60% 3 month share price decline. The 1 year total shareholder return of 8.86% contrasts with a 25.91% total shareholder return over five years, suggesting...
NYSE:VVX
NYSE:VVXAerospace & Defense

Is V2X (VVX) Offering Value After 42% One Year Share Price Gain?

Wondering if V2X at around US$68.83 is offering value or asking you to pay up? This article breaks down what the current price really implies. The stock has seen mixed short term moves, with a 2.5% decline over the last 7 days, a 2.5% gain over the last 30 days, and returns of 23.9% year to date and 42.0% over the past year. Recent attention on V2X has focused on its role within the Aerospace & Defense sector and how its contract profile and government exposure fit into broader investor...
NYSE:PK
NYSE:PKHotel and Resort REITs

Is Park Hotels & Resorts (PK) Pricing Reflect Its Recent 1-Year Share Price Rebound

Before looking at detailed valuation models, it helps to frame a simple question: is Park Hotels & Resorts fairly priced at its recent US$11.34 share price, or is the market mispricing it? Recent returns have been mixed, with the stock showing a 4.3% return over the last 7 days, 8.6% over 30 days, 5.3% year to date, a 30.4% return over 1 year, 30.7% over 3 years, and a 23.5% decline over 5 years. These moves sit against a backdrop of ongoing interest in large hotel and resort REITs. Investors...
NYSE:LVS
NYSE:LVSHospitality

Las Vegas Sands Upskilling Push Tests Link Between Talent And Earnings Power

Las Vegas Sands (NYSE:LVS) has introduced new workforce upskilling and leadership development programs across its US and Macao operations. The initiatives include an AI skills program and new training pathways for culinary and management staff. These programs build on earlier ESG-linked commitments, with a renewed focus on talent development and operational efficiency. For a company built around large-scale integrated resorts and premium hospitality, NYSE:LVS relies heavily on service...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

SoFi Technologies (SOFI) Is Up 13.9% After Launching FedNow Transfers And Big Business Banking Integration

In early April 2026, Galileo Financial Technologies announced that SoFi Bank, N.A. now offers instant, 24/7 FedNow® Service bank transfers powered by Galileo, while SoFi also introduced “Big Business Banking” to let enterprises manage fiat and crypto activity within a single, nationally chartered banking platform. Together, these launches highlight how SoFi is using its bank charter and technology stack to connect real-time payments with blockchain-based services for both consumers and...
NasdaqGS:SIMO
NasdaqGS:SIMOSemiconductor

Assessing Silicon Motion Technology (SIMO) After Its Outperformance And Shift Toward Higher Margin Datacenter Growth

Why Silicon Motion Technology (SIMO) Is Back on Investors’ Radar Interest in Silicon Motion Technology (NasdaqGS:SIMO) has picked up after Heartland Advisors highlighted the stock in a first quarter 2026 investor letter, pointing to recent outperformance and a shift toward higher margin applications. See our latest analysis for Silicon Motion Technology. The latest move, with a 6.82% 1 day share price return and 14.19% 7 day share price return to US$139.03, comes on top of a 48.28% year to...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle AWS Multicloud Link Tests Stickiness Of AI Workloads

Oracle (NYSE:ORCL) and Amazon Web Services announced a multicloud network partnership to link Oracle Cloud Infrastructure (OCI) and AWS with high performance, private interconnectivity. The agreement is aimed at making it easier for enterprises to move data and workloads between the two platforms, including AI and hybrid cloud applications. The move marks a shift in the relationship between two long time competitors, as large customers increasingly run mission critical systems across...
NYSE:MMM
NYSE:MMMIndustrials

Is It Time To Reassess 3M (MMM) After Mixed Share Price Performance?

If you are wondering whether 3M's current share price reflects its true worth, this breakdown will help you connect the recent share performance with what the underlying valuation signals suggest. The stock last closed at US$151.24, with returns of 1.4% over 7 days, 0.9% over 30 days, a 6.5% decline year to date, and 18.1% over the past year. Together, these figures give you a mixed picture of recent sentiment. Recent coverage around 3M has focused on its role as a large US industrials name...
NYSE:JNJ
NYSE:JNJPharmaceuticals

What Johnson & Johnson (JNJ)'s Q1 Revenue Gain And 64th Straight Dividend Hike Mean For Shareholders

In April 2026, Johnson & Johnson reported first-quarter sales of US$24,062 million versus US$21,893 million a year earlier, alongside a quarterly dividend increase of 3.1% to US$1.34 per share, marking its 64th consecutive annual raise. The combination of higher revenue, lower net income of US$5,235 million versus US$10,999 million, and a continued multi-decade dividend growth streak highlights how the company is balancing investment, earnings pressure and shareholder returns. We’ll now...
NYSE:UPS
NYSE:UPSLogistics

A Look At United Parcel Service (UPS) Valuation After Recent Share Price Rebound

United Parcel Service (UPS) is back in focus for investors after recent share price moves, with the stock closing at $103.57. The company’s multi segment logistics model and recent return profile are drawing fresh attention. See our latest analysis for United Parcel Service. Recent trading has been supportive, with a 1 month share price return of 6.33% and a 7 day share price return of 3.11%. The 1 year total shareholder return of 17.46% contrasts with a 3 year total shareholder return...
NYSE:SNAP
NYSE:SNAPInteractive Media and Services

Snap’s AI Layoffs Reshape Costs While Shares Trade Below Valuation Estimates

Snap (NYSE:SNAP) is cutting around 1,000 roles, about 16% of its workforce, in a major AI focused restructuring. The company is also closing open positions and reorganizing operations to prioritize AI driven efficiency and cost control. The move follows pressure from activist investors who have called for tighter expense management and portfolio simplification. For investors watching NYSE:SNAP, this shift comes at a time when the stock trades around $6.04 and recent performance has been...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Assessing Mirum Pharmaceuticals (MIRM) Valuation As Pivotal Trial Readouts And Hiring Plans Draw Fresh Attention

Mirum Pharmaceuticals (MIRM) is back in focus after the company highlighted four upcoming pivotal clinical study readouts over the next 18 months, along with new inducement equity awards granted to 12 new employees. See our latest analysis for Mirum Pharmaceuticals. Recent trading reflects mixed momentum, with a 4.1% 1 month share price return and a 23.5% year to date share price return. The 1 year total shareholder return of about 1.5x suggests strong longer term gains as attention builds...
NYSE:AXS
NYSE:AXSInsurance

A Look At AXIS Capital Holdings (AXS) Valuation After Recent Share Price Moves

What AXIS Capital Holdings (AXS) investors are watching right now AXIS Capital Holdings (AXS) has attracted fresh attention after recent share price moves, with the stock last closing at $100.74 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for AXIS Capital Holdings. The latest 1 day share price return of 1.35% comes after a softer year to date share price return decline of 3.38%. Longer term total shareholder returns of 7.95% over 1 year and...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

AMD Backs Wayve To Extend AI Compute Into Future Automotive Chips

AMD (NasdaqGS:AMD) has joined Arm and Qualcomm in a $1.2b Series D funding round for UK-based autonomous driving startup Wayve. The investment includes a technical collaboration that aims to use AMD compute platforms in future self-driving and advanced driver-assistance systems. This cross-industry move extends AMD's reach further into automotive AI and next generation mobility platforms. For investors following AMD, this move shows how the company is positioning its hardware for AI-heavy...
NYSE:MOD
NYSE:MODBuilding

Modine Refocuses On Data Center Growth With Spin Off And New Leader

Modine Manufacturing (NYSE:MOD) has created a dedicated Data Centers division and appointed Art Laszlo as President. The company plans to spin off its Performance Technologies segment to focus on its data center cooling business. These corporate changes aim to align the business more closely with demand for data center focused solutions. For investors tracking NYSE:MOD, these moves come with the shares at $238.14 and substantial multi year gains, including about 20.3% over the past 30 days...
NasdaqGS:FRSH
NasdaqGS:FRSHSoftware

Did Freshworks' (FRSH) Freddy AI Momentum and New Channel Chief Just Shift Its Investment Narrative?

Earlier this month, Freshworks Inc. announced that Kuntal Vahalia will become Senior Vice President, Partnership Channel, leading global partner strategy as the company intensifies its move upmarket and investment in employee experience offerings such as ITSM, ITAM, ITOM, and ESM. At the same time, Freshworks reported that its employee-experience business has surpassed US$500.00 million in annual recurring revenue with 20% year-over-year growth, while over 8,000 customers now use its AI...
NYSE:NVRI
NYSE:NVRICommercial Services

A Look At Enviri (NVRI) Valuation After Strong One Year Shareholder Returns

Enviri stock: context for recent performance Enviri (NVRI) has drawn investor attention after a period where the share price moved roughly in line with modest revenue growth of 2.7% and a reported net income loss of US$163.5 million. Over the past month, the stock shows an 8.5% gain and about a 5.3% rise in the past 3 months, while the latest close near US$19.55 reflects a market value of about US$1.6b. See our latest analysis for Enviri. While the latest share price of US$19.55 sits slightly...
NYSE:BABA
NYSE:BABAMultiline Retail

Alibaba’s New AI Models And Robotics Push Broaden Long Term Story

Alibaba Group Holding (NYSE:BABA) introduced two video focused AI models, Happy Horse and Happy Oyster, aimed at generating interactive videos, 3D scenes, and full game worlds. The company is also preparing to launch its first four legged robot and deepen robotics partnerships, expanding its AI use cases beyond cloud and e commerce. These moves reflect a broader push into creative AI and robotics, areas where major Chinese tech peers are already active. For investors tracking NYSE:BABA,...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Is Recursion Pharmaceuticals (RXRX) Turning Conference Spotlights Into a Durable AI Drug Discovery Edge?

On 13 April 2026, Recursion Pharmaceuticals, Inc. presented at the 25th Annual Needham Virtual Healthcare Conference, offering an update to investors and healthcare specialists on its progress in AI-enabled drug discovery. This conference appearance highlights how Recursion is using high-profile industry platforms to communicate its AI- and data-centric approach to drug development and partnerships. We’ll now examine how this Needham conference presentation, and the attention around it, may...
NYSE:V
NYSE:VDiversified Financial

Visa’s Tempo Validator Node Highlights Evolving Blockchain Payment Narrative

Visa has launched a validator node on the Tempo blockchain, taking an active role in validating and securing stablecoin transactions. This move places Visa directly in the core infrastructure for real time, agentic, and blockchain based payments. For investors watching NYSE:V, this update adds a new piece to the picture of Visa as a global payments infrastructure provider, not just a card network. The shares last closed at $315.91, with a return of 39.0% over 3 years and 44.1% over 5 years,...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Neurocrine Expands CNS Pipeline With Nxera Schizophrenia Trial And Milestones

Neurocrine Biosciences (NasdaqGS:NBIX) has started a Phase 2 clinical trial in schizophrenia for its candidate NBI-1117570. The trial, conducted in partnership with Nxera Pharma, has begun dosing the first patient. This program expands Neurocrine's development efforts beyond its established movement disorder focus. Neurocrine Biosciences enters this new study with its shares at $131.44 and a 1 year return of 31.3%. Over 3 and 5 years, returns of 25.3% and 35.5% reflect longer term share...
NYSE:SQM
NYSE:SQMChemicals

Does SQM’s New Cash Dividend Hint at a Shift in Its Lithium Growth and Capital Allocation Strategy?

Sociedad Química y Minera de Chile S.A. previously announced a quarterly dividend of US$0.6692 per share, with an ex-dividend and record date of May 8, 2026, and payment scheduled for May 26, 2026. This cash distribution may appeal to income-focused investors and can be read as a sign of management’s confidence in the company’s financial position. Now we’ll assess how this newly declared cash dividend interacts with SQM’s existing lithium‑driven growth narrative and capital allocation...